MEN1 family with a novel frameshift mutation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03344129PMID 16794369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

  2005cited by this paper
• The diagnosis and medical management of advanced neuroendocrine tumors.

  2004cited by this paper
• Functional Interaction between Tumor Suppressor Menin and Activator of S-Phase Kinase

  2004cited by this paper
• Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor β-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2*

  2004cited by this paper
• Molecular Pathology of the MEN1 Gene

  2004cited by this paper
• Menin associates with FANCD2, a protein involved in repair of DNA damage.

  2003cited by this paper
• The treatment of sporadic versus MEN1‐related pituitary adenomas

  2003cited by this paper
• Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex.

  2003cited by this paper
• Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.

  2002cited by this paper
• Adrenal Involvement in Multiple Endocrine Neoplasia Type 1

  2002cited by this paper
• Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance.

  2002cited by this paper
• Multiple endocrine neoplasia type 1 and adrenal lesions.

  2001cited by this paper
• CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

  2001cited by this paper
• Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.

  2001cited by this paper
• Multiple endocrine neoplasia type 1: new clinical and basic findings.

  2001cited by this paper
• Guidelines for diagnosis and therapy of MEN type 1 and type 2.

  2001cited by this paper
• Multiple Endocrine Neoplasia Type 1

  2000cited by this paper
• The octreotide suppression test and [111In‐DTPA‐D‐Phe1]‐octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment

  1998cited by this paper
• Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

  1997cited by this paper
• Positional cloning of the gene for multiple endocrine neoplasia-type 1.

  1997cited by this paper
• Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

  1996cited by this paper
• Corrigendum: Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (Q J Med (1996) 89 (653-659))

  1996cited by this paper
• Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred.

  1996cited by this paper
• Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1.

  1992cited by this paper
• The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

  1991cited by this paper
• Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma

  1988cited by this paper
• ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN.

  1963cited by this paper
• Genetic aspects of adenomatosis of endocrine glands.

  1954cited by this paper

• Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome–Related Skin Tumors

  2022influential citation
• TIO Associated with Hyperparathyroidism: A Rarity, a Rule, or a Novel HPT-PMT Syndrome—A Case Study with Literature Review

  2021cites this paper
• Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database

  2018cites this paper
• Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas

  2014cites this paper
• Combined Biological Therapy is Effective to Control all Neuroendocrine Tumor Manifestations in a Patient with MEN1 Syndrome

  2013cites this paper
• Hereditary Neuroendocrine Tumor Syndromes

  2013cites this paper
• Genetic Variation and its Role in Malignancy

  2011cites this paper
• Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.

  2008cites this paper
• Silent Familial Isolated Pituitary Adenomas: Histopathological and Clinical Case Report

  2008cites this paper